Medexus Pharmaceuticals Inc.

TSX:MDP 株式レポート

時価総額:CA$41.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Medexus Pharmaceuticals バランスシートの健全性

財務の健全性 基準チェック /36

Medexus Pharmaceuticalsの総株主資本は$29.6M 、総負債は$51.7Mで、負債比率は174.9%となります。総資産と総負債はそれぞれ$160.4Mと$130.8Mです。 Medexus Pharmaceuticalsの EBIT は$12.8Mで、利息カバレッジ比率0.9です。現金および短期投資は$8.2Mです。

主要情報

174.9%

負債資本比率

US$51.70m

負債

インタレスト・カバレッジ・レシオ0.9x
現金US$8.21m
エクイティUS$29.56m
負債合計US$130.82m
総資産US$160.38m

財務の健全性に関する最新情報

Recent updates

The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Jun 15
The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Apr 25
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Mar 03
Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Jan 06
Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Oct 11
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 11
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Jan 19
Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 22
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Dec 16
Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 21
Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Aug 04
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals Inc. (CVE:MDP): When Will It Breakeven?

May 04
Medexus Pharmaceuticals Inc. (CVE:MDP): When Will It Breakeven?

The Independent Director of Medexus Pharmaceuticals Inc. (CVE:MDP), Michael Mueller, Just Bought 34% More Shares

Feb 26
The Independent Director of Medexus Pharmaceuticals Inc. (CVE:MDP), Michael Mueller, Just Bought 34% More Shares

財務状況分析

短期負債: MDPの 短期資産 ( $74.1M ) が 短期負債 ( $66.5M ) を超えています。

長期負債: MDPの短期資産 ( $74.1M ) が 長期負債 ( $64.3M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: MDPの 純負債対資本比率 ( 147.1% ) は 高い と見なされます。

負債の削減: MDPの負債対資本比率は、過去 5 年間で39%から174.9%に増加しました。

債務返済能力: MDPの負債は 営業キャッシュフロー によって 十分にカバー されています ( 40.6% )。

インタレストカバレッジ: MDPの負債に対する 利息支払いEBIT ( 0.9 x coverage) によって 十分にカバーされていません


貸借対照表


健全な企業の発掘